Agence Nationale de Recherches sur le SIDA 088
Agence Nationale de Recherches sur le SIDA 090
Agence Nationale de Recherches sur le SIDA 097
Agence Nationale de Recherches sur le SIDA 106
Agence Nationale de Recherches sur le SIDA 107
Agence Nationale de Recherches sur le SIDA 109 Vista
Agence Nationale de Recherches sur le SIDA 1201/1202 DITRAME PLUS
Agence Nationale de Recherches sur le SIDA 12136 Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults
Agence Nationale de Recherches sur le SIDA 12174
Agence Nationale de Recherches sur le SIDA 12249 Treatment-as-Prevention
Agence Nationale de Recherches sur le SIDA 1244/1278
Agence Nationale de Recherches sur le SIDA 1265
Agence Nationale de Recherches sur le SIDA 1269 Trivacan
Agence Nationale de Recherches sur le SIDA 127
Agence Nationale de Recherches sur le SIDA 1285
Agence Nationale de Recherches sur le SIDA 1295
Agence Nationale de Recherches sur le SIDA. Combined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex With Men and Using Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC) for HIV Pre-Exposure Prophylaxis (PrEP)
Agence Nationale de Recherches sur le SIDA C03
Agence Nationale de Recherches sur le SIDA C08
Immunologic and Virologic Progression in HIV Controllers: The Role of Viral “Blips” and Immune Activation
Agence Nationale de Recherches sur le SIDA Factors of Access to New Therapy with Antiviral drugs for Subjects Infected with hepatitis C receiving Opioid agonist therapy
Agence Nationale de Recherches sur le SIDA HC EP07
Agence Nationale de Recherches sur le SIDA Intervention Préventive de l’Exposition aux Riskes avec et pour les GAYs
Agence Nationale de Recherches sur le SIDA PARCOURS Life Course, HIV and Hepatitis B Among African Migrants Living in Ile-de-France
Agence Nationale de Recherches sur le SIDA. Prevention of HIV in "Île-de-France
Agence Nationale de Recherches sur le SIDA VICONTI
Agence Nationale de Recherches sur le SIDA-EN12-VESPA
Agence Nationale de Recherches sur le SIDA-EN12-VESPA 2003. Management of HIV-related stigma and adherence to HAART: evidence from a large representative sample of outpatients attending French hospitals
Agence Nationale de Recherches sur le SIDA-EN13-VESPA-DFA
Agence Nationale de Recherches sur le SIDA-VIH: Enquête Sur les Personnes Atteintes2
Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa
American Nimodipine Study
Asian Network for Surveillance Of Resistant Pathogens
Acoustic Neuroma Subtotal Resection Study
Albumin for the treatmeNt of aScites in patients With hEpatic ciRrhosis
KANSai consortium for WEll-being of Rheumatic disease patients
Angiotensin Receptor-Neprilysin Inhibition in Chagas Cardiomyopathy With Reduced Ejection Fraction
A Multicenter, Randomized, Open-Label, Blinded Endpoint Evaluation, Active-Controlled, Dose-Ranging Study to Compare the Efficacy and Safety of i.v. MAA868 and s.c. Enoxaparin in Adult Patients Undergoing Elective Unilateral Total Knee Arthroplasty
Intravenous antazoline, a first‐generation antihistaminic drug with antiarrhythmic properties, is a suitable agent for pharmacological cardioversion of atrial fibrillation induced during pulmonary vein isolation due to the lack of influence on atrio‐venous conduction and high clinical effectiveness
Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome
Cryo-thawed embryo transfer: natural versus artificial cycle
Cryo-thawed embryo transfer: natural versus artificial cycle-2
Efficacy and Safety of the Biosimilar Natalizumab PB006 in Comparison to Tysabri®
Early versus delayed introduction of oral vitamin K antagonists in combination with low-molecular-weight heparin in the treatment of deep vein thrombosis
Antibiotherapy During Therapeutic Hypothermia to Prevent Infectious Complications
Antecedent Metabolic Health and Metformin Aging Study
Autonomic Neural regulation Therapy to Enhance Myocardial function in Heart Failure
Anticoagulation with rNAPc2 to Eliminate MACE-Thrombolysis In Myocardial Infarction 32
Anticoagulation in critically ill patients on mechanical ventilation suffering from COVID-19 disease
Antibiotic treatment for intermittent bladder catheterisation
Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation-Atrial Fibrillation NETwork 2
AspiriN To Inhibit SEPSIS
The AspiriN To Inhibit SEPSIS (ANTISEPSIS) trial; an ASPirin in Preventing Events in the Elderly, (ASPREE) Substudy to measure the benefit of low dose aspirin in the prevention of severe sepsis in the elderly
ANTidepressants to prevent reLapse in dEpRession
First-in-human trial of CB-010, a crispr-edited allogeneic anti-CD19 car -T cell therapy with a PD-1 knock out, in patients with relapsed or refractory B cell non-hodgkin lymphoma
Anorexia Nervosa Treatment of OutPatients
Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Asthma
Australian and New Zealand heart failure collaborative study
Australian and New Zealand 0502 Neoadjuvant Gemcitabine